Board of Directors has replenished the Company’s share repurchase authorization to an aggregate amount of $2.5 billion, consistent with the authorization limit previously approved by the Board in July 2025. This new reauthorization includes any amounts remaining under the Company’s pre-existing program.
As recently announced, the Company repurchased $500 million of its common stock in June 2026 as part of a block trade involving selling stockholders including certain funds affiliated with Mantle Ridge LP. Following that transaction, the Company had approximately $700 million remaining under its existing $2.5 billion authorization.
The Board’s authorization permits the Company to repurchase shares of its common stock from time to time in the open market or through privately negotiated transactions, subject to market and other conditions, up to the aggregate amount authorized by the Board. The Board’s authorization has no expiration date.